VN, Q., F, M., G, A., T, R., P, S., D, L., . . . GE, C. (2026). Exhaled acetylcholine in breath condensate as a non-invasive biomarker of asthma control: Insights from patients treated with extrafine single-inhaler triple therapy. Respiratory medicine, 261, 109030. https://doi.org/10.1016/j.rmed.2026.109030
Chicago Style (17th ed.) CitationVN, Quaranta, et al. "Exhaled Acetylcholine in Breath Condensate as a Non-invasive Biomarker of Asthma Control: Insights from Patients Treated with Extrafine Single-inhaler Triple Therapy." Respiratory Medicine 261 (2026): 109030. https://doi.org/10.1016/j.rmed.2026.109030.
MLA (9th ed.) CitationVN, Quaranta, et al. "Exhaled Acetylcholine in Breath Condensate as a Non-invasive Biomarker of Asthma Control: Insights from Patients Treated with Extrafine Single-inhaler Triple Therapy." Respiratory Medicine, vol. 261, 2026, p. 109030, https://doi.org/10.1016/j.rmed.2026.109030.